RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Suda Pharmaceuticals P/S 2024

Suda Pharmaceuticals P/S

7.29

Suda Pharmaceuticals Dividend yield

Ticker

SUD.AX

ISIN

AU000000SUD7

WKN

A1J9SF

As of May 31, 2024, Suda Pharmaceuticals's P/S ratio stood at 7.29, a 0% change from the 0 P/S ratio recorded in the previous year.

The Suda Pharmaceuticals P/S history

Suda Pharmaceuticals Aktienanalyse

What does Suda Pharmaceuticals do?

Suda Pharmaceuticals Ltd is an Australian pharmaceutical company specializing in the development and marketing of drugs. The company was founded in 2000 and is headquartered in Perth, Western Australia. It is listed on the Australian Stock Exchange and has offices in the UK and the USA. Suda Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/S Details

Decoding Suda Pharmaceuticals's P/S Ratio

Suda Pharmaceuticals's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.

Year-to-Year Comparison

Comparing Suda Pharmaceuticals's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.

Impact on Investments

The P/S ratio is instrumental for investors evaluating Suda Pharmaceuticals's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.

Interpreting P/S Ratio Fluctuations

Variations in Suda Pharmaceuticals’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.

Frequently Asked Questions about Suda Pharmaceuticals Stock

What is the price-to-earnings ratio of Suda Pharmaceuticals?

The price-earnings ratio of Suda Pharmaceuticals is currently 7.29.

How has the price-earnings ratio of Suda Pharmaceuticals changed compared to last year?

The price-to-earnings ratio of Suda Pharmaceuticals has increased by 0% increased compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Suda Pharmaceuticals high compared to other companies?

Yes, the price-to-earnings ratio of Suda Pharmaceuticals is high compared to other companies.

How does an increase in the price-earnings ratio of Suda Pharmaceuticals affect the company?

An increase in the price-earnings ratio of Suda Pharmaceuticals would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Suda Pharmaceuticals affect the company?

A decrease in the price-earnings ratio of Suda Pharmaceuticals would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Suda Pharmaceuticals?

Some factors that influence the price-earnings ratio of Suda Pharmaceuticals are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Suda Pharmaceuticals pay?

Over the past 12 months, Suda Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Suda Pharmaceuticals is expected to pay a dividend of 0 AUD.

What is the dividend yield of Suda Pharmaceuticals?

The current dividend yield of Suda Pharmaceuticals is .

When does Suda Pharmaceuticals pay dividends?

Suda Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Suda Pharmaceuticals?

Suda Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Suda Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 AUD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Suda Pharmaceuticals located?

Suda Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Suda Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Suda Pharmaceuticals from 5/31/2024 amounting to 0 AUD, you needed to have the stock in your portfolio before the ex-date on 5/31/2024.

When did Suda Pharmaceuticals pay the last dividend?

The last dividend was paid out on 5/31/2024.

What was the dividend of Suda Pharmaceuticals in the year 2023?

In the year 2023, Suda Pharmaceuticals distributed 0 AUD as dividends.

In which currency does Suda Pharmaceuticals pay out the dividend?

The dividends of Suda Pharmaceuticals are distributed in AUD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Suda Pharmaceuticals

Our stock analysis for Suda Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Suda Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.